Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection-Reference-Cited by-同舟云学术

Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection

Published:2015-08-04 Issue:1 Volume:18 Page:96-104
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro Oncol

Author:

Ringel Florian,Pape Haiko,Sabel Michael,Krex Dietmar,Bock Hans Christoph,Misch Martin,Weyerbrock Astrid,Westermaier Thomas,Senft Christian,Schucht Philippe,Meyer Bernhard,Simon Matthias

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/18/1/96/7640443/nov145.pdf

Reference50 articles.

1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

2. Standards of care for treatment of recurrent glioblastoma—are we there yet?

3. Efficacy of Fractionated Stereotactic Reirradiation in Recurrent Gliomas: Long-Term Results in 172 Patients Treated in a Single Institution

4. Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival

5. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cascade catalyzed dual-responsive Gold-Ferri “bomb-like” nanoreactors for positive feedback penetrating in sequential targeted triple glioblastoma therapy;Chemical Engineering Journal;2024-10

2. Re-irradiation treatment regimens for patients with recurrent glioma – Evaluation of the optimal dose and best concurrent therapy;Radiotherapy and Oncology;2024-10

3. Combined Statistical Analysis of Glioblastoma Outcomes—A Neurosurgical Single-Institution Retrospective Study;Medicina;2024-07-30

4. Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms;International Journal of Molecular Sciences;2024-06-19

5. MEX3A is a new diagnostic, independent prognostic biomarker and a promising therapeutic target in gliomas;2024-05-13